Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
399.50    -3.50 (-0.87%)
Bid:
399.00
Ask:
401.00
Spread: 2.00 (0.501%)
Market Cap: £138.78m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Director Dealings

28 Sep 2017 08:56

RNS Number : 0782S
Frontier Developments PLC
28 September 2017
Β 

28 September 2017

Β 

Frontier Developments plc

(the "Company")

Β 

Director and PCA Dealings

Β 

Further to the Company's announcements on 20 and 21 September 2017, the Company was notified on 27 September 2017 that Professional Practice Automation LLP ("PPA"), a limited liability partnership in which David Braben, Chief Executive Officer, was a member and through which he was interested in 2,001,573 ordinary shares of 0.5p each in the Company ("Ordinary Shares"), transferred 1,990,573 Ordinary Shares to Mr. Braben's spouse, Mrs. Irvin-Braben, on 27 September 2017 for nil consideration (the "Transfer"). In connection with the Transfer, Mr. Braben resigned as a member of PPA and is no longer interested in the remaining 11,000 Ordinary Shares held by PPA.

Β 

Therefore, following the Transfer and Mr Braben's resignation as a member of PPA, Mr. Braben, together with his spouse, remains interested in a total of 14,149,953 Ordinary Shares, representing 37.0% of the Company's issued share capital.

Β 

Β 

Enquiries:

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

Alex Bevis, CFO

Β 

Β 

Β 

Liberum - Nomad and Joint Broker

+44 (0)203 100 2000

Neil Patel / Cameron Duncan

Β 

Β 

Β 

Finncap

+44 (0) 207 220 0500

Matt Goode/Giles Rolls

Β 

Β 

Β 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White/Matt Low

Β 

Β 

Β About Frontier DevelopmentsΒ plc

Frontier Developments plc, listed on the AIM stock market (AIM: FDEV), is a leading independent game developer founded in 1994 by David Braben, co-author of the seminal 'Elite' game. Based in Cambridge, Frontier uses its proprietary 'COBRA' game development technology to create innovative games across videogame consoles, computers, smartphones and tablets.

Β 

www.frontier.co.ukΒ 

Β 

Β 

Β 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated ("PCA")

a)

Name: Professional Practice Automation LLP

2.

Reason for the notification

a)

Position/status: PCA of David Braben, Director (Chief Executive Officer)

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Transfer for nil consideration to David Braben's spouse, Wendy Irvin-Braben

c)

Price(s) and volume(s):

Price(s)

Volume(s)

Nil

1,990,573

Β 

d)

Aggregated information:

Not applicable - single transaction

e)

Date of the transactions: 27-Sep-17

f)

Place of the transaction: Outside a trading venue

Β 

Β 

Β 

Β 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

Β 

5.

Details of the person discharging managerial responsibilities/person closely associated ("PCA")

a)

Name: Wendy Irvin-Braben

6.

Reason for the notification

a)

Position/status: PCA of David Braben, Director (Chief Executive Officer)

b)

Initial notification/Amendment: Initial Notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Receipt of transfer for nil consideration

c)

Price(s) and volume(s):

Price(s)

Volume(s)

Nil

1,990,573

Β 

d)

Aggregated information:

Not applicable - single transaction

e)

Date of the transactions: 27-Sep-17

f)

Place of the transaction: Outside a trading venue

Β 

Β 

Β 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

Β 

9.

Details of the person discharging managerial responsibilities/person closely associated ("PCA")

a)

Name: David Braben

10.

Reason for the notification

a)

Position/status: Director, Chief Executive Officer

b)

Initial notification/Amendment: Initial Notification

11.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

12.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Resignation as member of PPA (no longer interested in 11,000 Ordinary Shares as a result)

c)

Price(s) and volume(s):

Price(s)

Volume(s)

Nil

11,000

Β 

d)

Aggregated information:

Not applicable - single transaction

e)

Date of the transactions: 27-Sep-17

f)

Place of the transaction: Outside a trading venue

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHSELSWAFWSEIU
Date   Source Headline
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSLaunch of on-market Share Buyback Programme
26th Feb 20267:00 amRNSBlock Listing Return
11th Feb 202610:45 amRNSOption Grants / PDMR Dealings
27th Jan 20263:43 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSExcellent H1 Results & full year outlook upgraded
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.